Xinjie Wang, Principal Investigator, Doctoral Advisor. Northwest A&F University - Cambridge University joint training PhD. From 2018 to 2021, he worked as an associate researcher and researcher at South China Normal University.  He joined AGIS in Oct 2021 and has led a research team focusing on the development of novel CRISPR editing and nucleic acid detection technologies, and the transmission mechanism of zoonotic pathogens. He has published more than 30 papers in such international journals as Molecular Cancer, Advanced Science, Science Bulletin, Molecular Therapy, and other journals. He was awarded the Best Paper Award of 2021 by Science Bulletin magazine the Excellent Paper Award of Suzhou Natural Science, and the Excellent Paper Award of the 7th China Association for Science and Technology Excellent Scientific Paper Selection Program. Applied for 3 international PCT patents and 12 national invention patents.